2/14/2007

First Venture Technologies reports several trials show its biotech yeast, designed for wine production, behaves similarly to the commercial parent strain during fermentation. The biotech strain reduces levels of the carcinogen ethyl carbamate in fermented foods and beverages, the company says.

Full Story:
FoodNavigator

Related Summaries